nodes	percent_of_prediction	percent_of_DWPC	metapath
Spironolactone—ABCC2—Vinblastine—head and neck cancer	0.204	0.34	CbGbCtD
Spironolactone—ABCC2—Docetaxel—head and neck cancer	0.168	0.281	CbGbCtD
Spironolactone—CYP2C8—Fluorouracil—head and neck cancer	0.106	0.177	CbGbCtD
Spironolactone—ABCB1—Vinblastine—head and neck cancer	0.0665	0.111	CbGbCtD
Spironolactone—ABCB1—Docetaxel—head and neck cancer	0.0549	0.0914	CbGbCtD
Spironolactone—AR—duct of salivary gland—head and neck cancer	0.0385	0.433	CbGeAlD
Spironolactone—Carcinoma breast—Docetaxel—head and neck cancer	0.0181	0.101	CcSEcCtD
Spironolactone—Gastrointestinal symptom NOS—Hydroxyurea—head and neck cancer	0.00802	0.0445	CcSEcCtD
Spironolactone—Drug fever—Docetaxel—head and neck cancer	0.00734	0.0408	CcSEcCtD
Spironolactone—Breast cancer—Docetaxel—head and neck cancer	0.00672	0.0373	CcSEcCtD
Spironolactone—Gastrointestinal symptom NOS—Fluorouracil—head and neck cancer	0.00578	0.0321	CcSEcCtD
Spironolactone—Amenorrhoea—Hydroxyurea—head and neck cancer	0.00537	0.0298	CcSEcCtD
Spironolactone—Ulcer—Hydroxyurea—head and neck cancer	0.00499	0.0277	CcSEcCtD
Spironolactone—Menstruation irregular—Docetaxel—head and neck cancer	0.00443	0.0246	CcSEcCtD
Spironolactone—Renal failure acute—Hydroxyurea—head and neck cancer	0.00371	0.0206	CcSEcCtD
Spironolactone—Ulcer—Fluorouracil—head and neck cancer	0.00359	0.0199	CcSEcCtD
Spironolactone—Rash erythematous—Docetaxel—head and neck cancer	0.0032	0.0178	CcSEcCtD
Spironolactone—SHBG—neck—head and neck cancer	0.00305	0.0343	CbGeAlD
Spironolactone—Amenorrhoea—Docetaxel—head and neck cancer	0.00279	0.0155	CcSEcCtD
Spironolactone—Agranulocytosis—Vinblastine—head and neck cancer	0.0027	0.015	CcSEcCtD
Spironolactone—Drowsiness—Hydroxyurea—head and neck cancer	0.00264	0.0147	CcSEcCtD
Spironolactone—Lethargy—Fluorouracil—head and neck cancer	0.00252	0.014	CcSEcCtD
Spironolactone—NR3C2—parotid gland—head and neck cancer	0.00241	0.027	CbGeAlD
Spironolactone—Ataxia—Fluorouracil—head and neck cancer	0.00232	0.0129	CcSEcCtD
Spironolactone—NR3C2—saliva-secreting gland—head and neck cancer	0.00231	0.0259	CbGeAlD
Spironolactone—Alopecia—Vinblastine—head and neck cancer	0.0023	0.0127	CcSEcCtD
Spironolactone—SHBG—connective tissue—head and neck cancer	0.00219	0.0246	CbGeAlD
Spironolactone—NR3C2—connective tissue—head and neck cancer	0.00212	0.0238	CbGeAlD
Spironolactone—Eosinophilia—Fluorouracil—head and neck cancer	0.00211	0.0117	CcSEcCtD
Spironolactone—Ill-defined disorder—Vinblastine—head and neck cancer	0.0021	0.0117	CcSEcCtD
Spironolactone—Alopecia—Hydroxyurea—head and neck cancer	0.00209	0.0116	CcSEcCtD
Spironolactone—Malaise—Vinblastine—head and neck cancer	0.00204	0.0113	CcSEcCtD
Spironolactone—Leukopenia—Vinblastine—head and neck cancer	0.00202	0.0112	CcSEcCtD
Spironolactone—CYP11B2—lymph node—head and neck cancer	0.00198	0.0222	CbGeAlD
Spironolactone—PGR—connective tissue—head and neck cancer	0.00197	0.0221	CbGeAlD
Spironolactone—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.00191	0.0106	CcSEcCtD
Spironolactone—Discomfort—Vinblastine—head and neck cancer	0.0019	0.0106	CcSEcCtD
Spironolactone—PGR—epithelium—head and neck cancer	0.00187	0.021	CbGeAlD
Spironolactone—Malaise—Hydroxyurea—head and neck cancer	0.00186	0.0103	CcSEcCtD
Spironolactone—Leukopenia—Hydroxyurea—head and neck cancer	0.00185	0.0103	CcSEcCtD
Spironolactone—Lethargy—Docetaxel—head and neck cancer	0.00182	0.0101	CcSEcCtD
Spironolactone—Thrombocytopenia—Vinblastine—head and neck cancer	0.00181	0.01	CcSEcCtD
Spironolactone—NR3C2—trachea—head and neck cancer	0.00178	0.02	CbGeAlD
Spironolactone—Agranulocytosis—Fluorouracil—head and neck cancer	0.00177	0.00984	CcSEcCtD
Spironolactone—Discomfort—Hydroxyurea—head and neck cancer	0.00173	0.00963	CcSEcCtD
Spironolactone—Ataxia—Docetaxel—head and neck cancer	0.00167	0.00929	CcSEcCtD
Spironolactone—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.00165	0.00915	CcSEcCtD
Spironolactone—Toxic epidermal necrolysis—Docetaxel—head and neck cancer	0.0016	0.0089	CcSEcCtD
Spironolactone—Cramp muscle—Docetaxel—head and neck cancer	0.0016	0.0089	CcSEcCtD
Spironolactone—NR3C1—neck—head and neck cancer	0.00159	0.0178	CbGeAlD
Spironolactone—AR—connective tissue—head and neck cancer	0.00157	0.0176	CbGeAlD
Spironolactone—Feeling abnormal—Vinblastine—head and neck cancer	0.00152	0.00844	CcSEcCtD
Spironolactone—Alopecia—Fluorouracil—head and neck cancer	0.00151	0.00837	CcSEcCtD
Spironolactone—Somnolence—Hydroxyurea—head and neck cancer	0.0015	0.00831	CcSEcCtD
Spironolactone—AR—epithelium—head and neck cancer	0.00149	0.0167	CbGeAlD
Spironolactone—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.00145	0.00807	CcSEcCtD
Spironolactone—SHBG—thyroid gland—head and neck cancer	0.00145	0.0163	CbGeAlD
Spironolactone—PGR—lymphoid tissue—head and neck cancer	0.00144	0.0162	CbGeAlD
Spironolactone—NR3C2—thyroid gland—head and neck cancer	0.00141	0.0158	CbGeAlD
Spironolactone—Feeling abnormal—Hydroxyurea—head and neck cancer	0.00139	0.0077	CcSEcCtD
Spironolactone—Hypersensitivity—Vinblastine—head and neck cancer	0.00136	0.00755	CcSEcCtD
Spironolactone—Stevens-Johnson syndrome—Docetaxel—head and neck cancer	0.00136	0.00755	CcSEcCtD
Spironolactone—Renal failure—Docetaxel—head and neck cancer	0.00135	0.00748	CcSEcCtD
Spironolactone—Body temperature increased—Hydroxyurea—head and neck cancer	0.00133	0.00739	CcSEcCtD
Spironolactone—Leukopenia—Fluorouracil—head and neck cancer	0.00133	0.00738	CcSEcCtD
Spironolactone—PGR—thyroid gland—head and neck cancer	0.00131	0.0147	CbGeAlD
Spironolactone—NR3C1—parotid gland—head and neck cancer	0.00129	0.0145	CbGeAlD
Spironolactone—Agranulocytosis—Docetaxel—head and neck cancer	0.00128	0.0071	CcSEcCtD
Spironolactone—Diarrhoea—Vinblastine—head and neck cancer	0.00126	0.00701	CcSEcCtD
Spironolactone—NR3C2—head—head and neck cancer	0.00125	0.014	CbGeAlD
Spironolactone—Discomfort—Fluorouracil—head and neck cancer	0.00125	0.00693	CcSEcCtD
Spironolactone—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00124	0.00689	CcSEcCtD
Spironolactone—NR3C1—saliva-secreting gland—head and neck cancer	0.00124	0.0139	CbGeAlD
Spironolactone—Confusional state—Fluorouracil—head and neck cancer	0.00122	0.00678	CcSEcCtD
Spironolactone—Dizziness—Vinblastine—head and neck cancer	0.00122	0.00678	CcSEcCtD
Spironolactone—Anaphylactic shock—Fluorouracil—head and neck cancer	0.00121	0.00673	CcSEcCtD
Spironolactone—Thrombocytopenia—Fluorouracil—head and neck cancer	0.00119	0.00659	CcSEcCtD
Spironolactone—Vomiting—Vinblastine—head and neck cancer	0.00117	0.00652	CcSEcCtD
Spironolactone—Erythema multiforme—Docetaxel—head and neck cancer	0.00116	0.00646	CcSEcCtD
Spironolactone—PGR—head—head and neck cancer	0.00116	0.013	CbGeAlD
Spironolactone—Headache—Vinblastine—head and neck cancer	0.00116	0.00642	CcSEcCtD
Spironolactone—Diarrhoea—Hydroxyurea—head and neck cancer	0.00115	0.00639	CcSEcCtD
Spironolactone—AR—lymphoid tissue—head and neck cancer	0.00115	0.0129	CbGeAlD
Spironolactone—NR3C1—connective tissue—head and neck cancer	0.00114	0.0128	CbGeAlD
Spironolactone—Dizziness—Hydroxyurea—head and neck cancer	0.00111	0.00618	CcSEcCtD
Spironolactone—Nausea—Vinblastine—head and neck cancer	0.0011	0.00609	CcSEcCtD
Spironolactone—Alopecia—Docetaxel—head and neck cancer	0.00109	0.00604	CcSEcCtD
Spironolactone—NR3C1—epithelium—head and neck cancer	0.00108	0.0121	CbGeAlD
Spironolactone—Somnolence—Fluorouracil—head and neck cancer	0.00108	0.00598	CcSEcCtD
Spironolactone—SLCO1A2—head—head and neck cancer	0.00107	0.012	CbGeAlD
Spironolactone—Vomiting—Hydroxyurea—head and neck cancer	0.00107	0.00594	CcSEcCtD
Spironolactone—Rash—Hydroxyurea—head and neck cancer	0.00106	0.00589	CcSEcCtD
Spironolactone—Dermatitis—Hydroxyurea—head and neck cancer	0.00106	0.00589	CcSEcCtD
Spironolactone—Headache—Hydroxyurea—head and neck cancer	0.00105	0.00585	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.00105	0.00581	CcSEcCtD
Spironolactone—AR—thyroid gland—head and neck cancer	0.00104	0.0117	CbGeAlD
Spironolactone—Muscle spasms—Docetaxel—head and neck cancer	0.00103	0.00572	CcSEcCtD
Spironolactone—Nausea—Hydroxyurea—head and neck cancer	0.001	0.00555	CcSEcCtD
Spironolactone—Feeling abnormal—Fluorouracil—head and neck cancer	0.000998	0.00554	CcSEcCtD
Spironolactone—Urticaria—Fluorouracil—head and neck cancer	0.000963	0.00534	CcSEcCtD
Spironolactone—Leukopenia—Docetaxel—head and neck cancer	0.000959	0.00533	CcSEcCtD
Spironolactone—Body temperature increased—Fluorouracil—head and neck cancer	0.000958	0.00532	CcSEcCtD
Spironolactone—NR3C1—trachea—head and neck cancer	0.000955	0.0107	CbGeAlD
Spironolactone—AR—head—head and neck cancer	0.000925	0.0104	CbGeAlD
Spironolactone—Hypersensitivity—Fluorouracil—head and neck cancer	0.000893	0.00496	CcSEcCtD
Spironolactone—Confusional state—Docetaxel—head and neck cancer	0.000882	0.0049	CcSEcCtD
Spironolactone—NR3C2—lymph node—head and neck cancer	0.000875	0.00982	CbGeAlD
Spironolactone—Anaphylactic shock—Docetaxel—head and neck cancer	0.000874	0.00486	CcSEcCtD
Spironolactone—Pruritus—Fluorouracil—head and neck cancer	0.000857	0.00476	CcSEcCtD
Spironolactone—Thrombocytopenia—Docetaxel—head and neck cancer	0.000856	0.00475	CcSEcCtD
Spironolactone—NR3C1—lymphoid tissue—head and neck cancer	0.000832	0.00933	CbGeAlD
Spironolactone—Diarrhoea—Fluorouracil—head and neck cancer	0.000829	0.0046	CcSEcCtD
Spironolactone—PGR—lymph node—head and neck cancer	0.000813	0.00913	CbGeAlD
Spironolactone—Dizziness—Fluorouracil—head and neck cancer	0.000801	0.00445	CcSEcCtD
Spironolactone—Somnolence—Docetaxel—head and neck cancer	0.000777	0.00432	CcSEcCtD
Spironolactone—Vomiting—Fluorouracil—head and neck cancer	0.00077	0.00428	CcSEcCtD
Spironolactone—Rash—Fluorouracil—head and neck cancer	0.000764	0.00424	CcSEcCtD
Spironolactone—NR3C2—Generic Transcription Pathway—RARB—head and neck cancer	0.000763	0.00589	CbGpPWpGaD
Spironolactone—Dermatitis—Fluorouracil—head and neck cancer	0.000763	0.00424	CcSEcCtD
Spironolactone—Headache—Fluorouracil—head and neck cancer	0.000759	0.00421	CcSEcCtD
Spironolactone—NR3C1—Adipogenesis—STAT6—head and neck cancer	0.000756	0.00584	CbGpPWpGaD
Spironolactone—NR3C1—thyroid gland—head and neck cancer	0.000755	0.00848	CbGeAlD
Spironolactone—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.000755	0.00419	CcSEcCtD
Spironolactone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK1—head and neck cancer	0.00074	0.00571	CbGpPWpGaD
Spironolactone—CYP11B2—Biological oxidations—GSTM1—head and neck cancer	0.000738	0.00569	CbGpPWpGaD
Spironolactone—CYP11B2—Metapathway biotransformation—GSTM1—head and neck cancer	0.000728	0.00561	CbGpPWpGaD
Spironolactone—Feeling abnormal—Docetaxel—head and neck cancer	0.000721	0.004	CcSEcCtD
Spironolactone—Nausea—Fluorouracil—head and neck cancer	0.00072	0.004	CcSEcCtD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—RARB—head and neck cancer	0.000713	0.0055	CbGpPWpGaD
Spironolactone—ABCC2—NRF2 pathway—TGFA—head and neck cancer	0.000712	0.00549	CbGpPWpGaD
Spironolactone—CYP11B2—Biological oxidations—CYP1A1—head and neck cancer	0.000699	0.00539	CbGpPWpGaD
Spironolactone—ABCC2—lymph node—head and neck cancer	0.000699	0.00784	CbGeAlD
Spironolactone—NR3C2—Generic Transcription Pathway—YAP1—head and neck cancer	0.000694	0.00536	CbGpPWpGaD
Spironolactone—AR—Nongenotropic Androgen signaling—MAPK3—head and neck cancer	0.000693	0.00534	CbGpPWpGaD
Spironolactone—Body temperature increased—Docetaxel—head and neck cancer	0.000691	0.00384	CcSEcCtD
Spironolactone—CYP11B2—Metapathway biotransformation—CYP1A1—head and neck cancer	0.00069	0.00532	CbGpPWpGaD
Spironolactone—NR3C1—head—head and neck cancer	0.00067	0.00752	CbGeAlD
Spironolactone—AR—Coregulation of Androgen receptor activity—CASP8—head and neck cancer	0.000664	0.00512	CbGpPWpGaD
Spironolactone—AR—Nongenotropic Androgen signaling—MAPK1—head and neck cancer	0.000659	0.00508	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—RAD51—head and neck cancer	0.000649	0.005	CbGpPWpGaD
Spironolactone—AR—lymph node—head and neck cancer	0.000648	0.00727	CbGeAlD
Spironolactone—Hypersensitivity—Docetaxel—head and neck cancer	0.000644	0.00358	CcSEcCtD
Spironolactone—CYP11B1—Biological oxidations—GSTM1—head and neck cancer	0.000636	0.0049	CbGpPWpGaD
Spironolactone—CYP11B1—Metapathway biotransformation—GSTM1—head and neck cancer	0.000627	0.00484	CbGpPWpGaD
Spironolactone—CYP11B1—Corticotropin-releasing hormone—BCL2—head and neck cancer	0.000622	0.0048	CbGpPWpGaD
Spironolactone—Pruritus—Docetaxel—head and neck cancer	0.000619	0.00344	CcSEcCtD
Spironolactone—PGR—Validated nuclear estrogen receptor alpha network—CCND1—head and neck cancer	0.000617	0.00476	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—UROD—head and neck cancer	0.000615	0.00474	CbGpPWpGaD
Spironolactone—CYP11B1—Biological oxidations—CYP1A1—head and neck cancer	0.000603	0.00465	CbGpPWpGaD
Spironolactone—Drospirenone—PTGS2—head and neck cancer	0.0006	0.455	CrCbGaD
Spironolactone—Diarrhoea—Docetaxel—head and neck cancer	0.000598	0.00332	CcSEcCtD
Spironolactone—CYP11B1—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000594	0.00458	CbGpPWpGaD
Spironolactone—Dizziness—Docetaxel—head and neck cancer	0.000578	0.00321	CcSEcCtD
Spironolactone—ABCB1—epithelium—head and neck cancer	0.000578	0.00649	CbGeAlD
Spironolactone—AR—Nongenotropic Androgen signaling—PIK3CA—head and neck cancer	0.000572	0.00441	CbGpPWpGaD
Spironolactone—Vomiting—Docetaxel—head and neck cancer	0.000556	0.00309	CcSEcCtD
Spironolactone—Rash—Docetaxel—head and neck cancer	0.000551	0.00306	CcSEcCtD
Spironolactone—Dermatitis—Docetaxel—head and neck cancer	0.000551	0.00306	CcSEcCtD
Spironolactone—CYP11B1—Corticotropin-releasing hormone—IL2—head and neck cancer	0.000548	0.00423	CbGpPWpGaD
Spironolactone—Headache—Docetaxel—head and neck cancer	0.000548	0.00304	CcSEcCtD
Spironolactone—CYP11B1—Metabolism—UROD—head and neck cancer	0.00053	0.00409	CbGpPWpGaD
Spironolactone—AR—Nongenotropic Androgen signaling—HRAS—head and neck cancer	0.000529	0.00408	CbGpPWpGaD
Spironolactone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDH1—head and neck cancer	0.000528	0.00407	CbGpPWpGaD
Spironolactone—AR—Notch-mediated HES/HEY network—STAT3—head and neck cancer	0.00052	0.00401	CbGpPWpGaD
Spironolactone—Nausea—Docetaxel—head and neck cancer	0.000519	0.00288	CcSEcCtD
Spironolactone—ABCB1—trachea—head and neck cancer	0.000511	0.00574	CbGeAlD
Spironolactone—NR3C1—Endoderm Differentiation—NOTCH1—head and neck cancer	0.000507	0.00391	CbGpPWpGaD
Spironolactone—CYP2C8—Arachidonic acid metabolism—GPX1—head and neck cancer	0.000504	0.00389	CbGpPWpGaD
Spironolactone—CYP2C8—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.000499	0.00385	CbGpPWpGaD
Spironolactone—AR—Coregulation of Androgen receptor activity—CCND1—head and neck cancer	0.000489	0.00377	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000477	0.00368	CbGpPWpGaD
Spironolactone—NR3C1—lymph node—head and neck cancer	0.000469	0.00527	CbGeAlD
Spironolactone—AR—Nongenotropic Androgen signaling—AKT1—head and neck cancer	0.000467	0.0036	CbGpPWpGaD
Spironolactone—PGR—Generic Transcription Pathway—RARB—head and neck cancer	0.000465	0.00359	CbGpPWpGaD
Spironolactone—ABCB1—lymphoid tissue—head and neck cancer	0.000445	0.005	CbGeAlD
Spironolactone—CYP11B1—Corticotropin-releasing hormone—MAPK3—head and neck cancer	0.000441	0.0034	CbGpPWpGaD
Spironolactone—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000431	0.00333	CbGpPWpGaD
Spironolactone—CYP2C8—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000426	0.00328	CbGpPWpGaD
Spironolactone—PGR—Generic Transcription Pathway—YAP1—head and neck cancer	0.000423	0.00326	CbGpPWpGaD
Spironolactone—CYP11B1—Corticotropin-releasing hormone—MAPK1—head and neck cancer	0.000419	0.00323	CbGpPWpGaD
Spironolactone—ABCC2—NRF2 pathway—GSTM1—head and neck cancer	0.000414	0.00319	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000411	0.00317	CbGpPWpGaD
Spironolactone—ABCB1—thyroid gland—head and neck cancer	0.000404	0.00454	CbGeAlD
Spironolactone—CYP2C8—Biological oxidations—NAT2—head and neck cancer	0.000397	0.00306	CbGpPWpGaD
Spironolactone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—head and neck cancer	0.000393	0.00303	CbGpPWpGaD
Spironolactone—CYP2C8—Metapathway biotransformation—NAT2—head and neck cancer	0.000391	0.00302	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—TYMS—head and neck cancer	0.00039	0.003	CbGpPWpGaD
Spironolactone—SLCO1A2—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000373	0.00288	CbGpPWpGaD
Spironolactone—Progesterone—CYP1A1—head and neck cancer	0.00037	0.28	CrCbGaD
Spironolactone—NR3C2—Gene Expression—RARB—head and neck cancer	0.000367	0.00283	CbGpPWpGaD
Spironolactone—AR—Androgen receptor signaling pathway—CCND1—head and neck cancer	0.000361	0.00279	CbGpPWpGaD
Spironolactone—ABCB1—head—head and neck cancer	0.000359	0.00403	CbGeAlD
Spironolactone—AR—Generic Transcription Pathway—RARB—head and neck cancer	0.000354	0.00273	CbGpPWpGaD
Spironolactone—Testosterone—CYP1A1—head and neck cancer	0.00035	0.265	CrCbGaD
Spironolactone—CYP2C8—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.00035	0.0027	CbGpPWpGaD
Spironolactone—AR—Androgen receptor signaling pathway—PTEN—head and neck cancer	0.000349	0.00269	CbGpPWpGaD
Spironolactone—NR3C1—AP-1 transcription factor network—IL2—head and neck cancer	0.000341	0.00263	CbGpPWpGaD
Spironolactone—ABCC2—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000339	0.00262	CbGpPWpGaD
Spironolactone—NR3C2—Gene Expression—YAP1—head and neck cancer	0.000334	0.00258	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—UROD—head and neck cancer	0.000332	0.00256	CbGpPWpGaD
Spironolactone—NR3C1—AP-1 transcription factor network—CCND1—head and neck cancer	0.000332	0.00256	CbGpPWpGaD
Spironolactone—AR—Generic Transcription Pathway—YAP1—head and neck cancer	0.000322	0.00249	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—CASP8—head and neck cancer	0.000321	0.00248	CbGpPWpGaD
Spironolactone—NR3C1—AP-1 transcription factor network—PTEN—head and neck cancer	0.000321	0.00247	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—CDH1—head and neck cancer	0.000318	0.00245	CbGpPWpGaD
Spironolactone—NR3C2—Generic Transcription Pathway—NOTCH1—head and neck cancer	0.000313	0.00241	CbGpPWpGaD
Spironolactone—AR—Androgen receptor signaling pathway—STAT3—head and neck cancer	0.000312	0.00241	CbGpPWpGaD
Spironolactone—NR3C1—Glucocorticoid receptor regulatory network—IL2—head and neck cancer	0.0003	0.00232	CbGpPWpGaD
Spironolactone—PGR—Signaling by ERBB4—PTEN—head and neck cancer	0.000298	0.0023	CbGpPWpGaD
Spironolactone—CYP11B1—Corticotropin-releasing hormone—AKT1—head and neck cancer	0.000297	0.00229	CbGpPWpGaD
Spironolactone—CYP2C8—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000297	0.00229	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—RARB—head and neck cancer	0.000291	0.00224	CbGpPWpGaD
Spironolactone—AR—Androgen receptor signaling pathway—EGFR—head and neck cancer	0.000283	0.00219	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—BCL2—head and neck cancer	0.000276	0.00213	CbGpPWpGaD
Spironolactone—AR—Coregulation of Androgen receptor activity—AKT1—head and neck cancer	0.000272	0.0021	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	0.000271	0.00209	CbGpPWpGaD
Spironolactone—NR3C1—Generic Transcription Pathway—RARB—head and neck cancer	0.000269	0.00207	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	0.000269	0.00207	CbGpPWpGaD
Spironolactone—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—head and neck cancer	0.000268	0.00207	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	0.000266	0.00205	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—RAD51—head and neck cancer	0.000264	0.00204	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000258	0.00199	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—NAT2—head and neck cancer	0.000255	0.00197	CbGpPWpGaD
Spironolactone—PGR—Signaling by ERBB4—MAPK3—head and neck cancer	0.000255	0.00197	CbGpPWpGaD
Spironolactone—ABCB1—lymph node—head and neck cancer	0.000251	0.00282	CbGeAlD
Spironolactone—NR3C1—Generic Transcription Pathway—YAP1—head and neck cancer	0.000244	0.00189	CbGpPWpGaD
Spironolactone—PGR—Signaling by ERBB4—MAPK1—head and neck cancer	0.000242	0.00187	CbGpPWpGaD
Spironolactone—PGR—Signaling by ERBB4—EGFR—head and neck cancer	0.000242	0.00187	CbGpPWpGaD
Spironolactone—NR3C1—Glucocorticoid receptor regulatory network—MAPK3—head and neck cancer	0.000241	0.00186	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—CCND1—head and neck cancer	0.000237	0.00183	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	0.000234	0.0018	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	0.000231	0.00179	CbGpPWpGaD
Spironolactone—NR3C1—Glucocorticoid receptor regulatory network—MAPK1—head and neck cancer	0.00023	0.00177	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	0.000228	0.00176	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—PTEN—head and neck cancer	0.000228	0.00176	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—DPYD—head and neck cancer	0.000224	0.00173	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—RARB—head and neck cancer	0.000224	0.00173	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—NAT2—head and neck cancer	0.00022	0.0017	CbGpPWpGaD
Spironolactone—ABCB1—Allograft Rejection—CASP8—head and neck cancer	0.00022	0.0017	CbGpPWpGaD
Spironolactone—NR3C1—AP-1 transcription factor network—TP53—head and neck cancer	0.000219	0.00169	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	0.000217	0.00167	CbGpPWpGaD
Spironolactone—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—head and neck cancer	0.000217	0.00167	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—YAP1—head and neck cancer	0.000213	0.00164	CbGpPWpGaD
Spironolactone—PGR—Signaling by ERBB4—PIK3CA—head and neck cancer	0.00021	0.00162	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—VEGFA—head and neck cancer	0.000206	0.00159	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—YAP1—head and neck cancer	0.000204	0.00157	CbGpPWpGaD
Spironolactone—AR—SIDS Susceptibility Pathways—VEGFA—head and neck cancer	0.000201	0.00155	CbGpPWpGaD
Spironolactone—AR—Androgen receptor signaling pathway—AKT1—head and neck cancer	0.000201	0.00155	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	0.000196	0.00151	CbGpPWpGaD
Spironolactone—CYP2C8—Biological oxidations—GSTM1—head and neck cancer	0.000196	0.00151	CbGpPWpGaD
Spironolactone—PGR—Signaling by ERBB4—HRAS—head and neck cancer	0.000195	0.0015	CbGpPWpGaD
Spironolactone—CYP2C8—Metapathway biotransformation—GSTM1—head and neck cancer	0.000193	0.00149	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—DPYD—head and neck cancer	0.000193	0.00149	CbGpPWpGaD
Spironolactone—NR3C1—Glucocorticoid receptor regulatory network—TP53—head and neck cancer	0.000193	0.00149	CbGpPWpGaD
Spironolactone—PGR—Generic Transcription Pathway—NOTCH1—head and neck cancer	0.000191	0.00147	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	0.000189	0.00146	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—KISS1—head and neck cancer	0.000187	0.00144	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—MAPK1—head and neck cancer	0.000186	0.00143	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—EGFR—head and neck cancer	0.000186	0.00143	CbGpPWpGaD
Spironolactone—CYP2C8—Biological oxidations—CYP1A1—head and neck cancer	0.000186	0.00143	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—YAP1—head and neck cancer	0.000183	0.00141	CbGpPWpGaD
Spironolactone—CYP2C8—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000183	0.00141	CbGpPWpGaD
Spironolactone—NR3C1—Adipogenesis—STAT3—head and neck cancer	0.000175	0.00135	CbGpPWpGaD
Spironolactone—PGR—Signaling by ERBB4—AKT1—head and neck cancer	0.000172	0.00133	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	0.000171	0.00132	CbGpPWpGaD
Spironolactone—AR—Gene Expression—RARB—head and neck cancer	0.000171	0.00132	CbGpPWpGaD
Spironolactone—ABCB1—Allograft Rejection—IL2—head and neck cancer	0.000166	0.00128	CbGpPWpGaD
Spironolactone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—head and neck cancer	0.000164	0.00127	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—UROD—head and neck cancer	0.000163	0.00126	CbGpPWpGaD
Spironolactone—ABCB1—HIF-1-alpha transcription factor network—VEGFA—head and neck cancer	0.000163	0.00126	CbGpPWpGaD
Spironolactone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—head and neck cancer	0.000163	0.00126	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	0.000162	0.00125	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	0.00016	0.00123	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.00016	0.00123	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—head and neck cancer	0.000159	0.00122	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—TP53—head and neck cancer	0.000156	0.0012	CbGpPWpGaD
Spironolactone—AR—Gene Expression—YAP1—head and neck cancer	0.000155	0.0012	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—GRP—head and neck cancer	0.000154	0.00119	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	0.000154	0.00119	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	0.000154	0.00119	CbGpPWpGaD
Spironolactone—NR3C1—SIDS Susceptibility Pathways—VEGFA—head and neck cancer	0.000153	0.00118	CbGpPWpGaD
Spironolactone—NR3C2—Gene Expression—NOTCH1—head and neck cancer	0.000151	0.00116	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—STAT6—head and neck cancer	0.00015	0.00115	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	0.000147	0.00113	CbGpPWpGaD
Spironolactone—AR—Generic Transcription Pathway—NOTCH1—head and neck cancer	0.000145	0.00112	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	0.000145	0.00112	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—UROD—head and neck cancer	0.000142	0.0011	CbGpPWpGaD
Spironolactone—ABCB1—Allograft Rejection—VEGFA—head and neck cancer	0.000141	0.00109	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	0.000139	0.00107	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—NAT2—head and neck cancer	0.000138	0.00106	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	0.000138	0.00106	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	0.000134	0.00103	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—YAP1—head and neck cancer	0.000132	0.00102	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—AKT1—head and neck cancer	0.000132	0.00102	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—RARB—head and neck cancer	0.000129	0.000998	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	0.000129	0.000996	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—TYMS—head and neck cancer	0.000128	0.000984	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000127	0.000977	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—GSTM1—head and neck cancer	0.000126	0.000973	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—DPYD—head and neck cancer	0.000121	0.000934	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—GPX1—head and neck cancer	0.000121	0.000932	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	0.00012	0.000926	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—CYP1A1—head and neck cancer	0.00012	0.000923	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—YAP1—head and neck cancer	0.000118	0.000908	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—YAP1—head and neck cancer	0.000115	0.000886	CbGpPWpGaD
Spironolactone—NR3C1—Generic Transcription Pathway—NOTCH1—head and neck cancer	0.00011	0.00085	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—TYMS—head and neck cancer	0.00011	0.000848	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	0.000109	0.000841	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—GSTM1—head and neck cancer	0.000109	0.000839	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	0.000109	0.000837	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—GPX1—head and neck cancer	0.000104	0.000803	CbGpPWpGaD
Spironolactone—ABCB1—HIF-1-alpha transcription factor network—AKT1—head and neck cancer	0.000104	0.000802	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—CYP1A1—head and neck cancer	0.000103	0.000795	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	9.83e-05	0.000758	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	9.31e-05	0.000718	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—NOTCH1—head and neck cancer	9.18e-05	0.000708	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	8.85e-05	0.000682	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	8.63e-05	0.000666	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	8.47e-05	0.000653	CbGpPWpGaD
Spironolactone—NR3C2—Gene Expression—MAPK3—head and neck cancer	8.34e-05	0.000643	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	7.99e-05	0.000617	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	7.72e-05	0.000595	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	7.53e-05	0.00058	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	7.2e-05	0.000556	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	7.13e-05	0.00055	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—PTGS2—head and neck cancer	7.11e-05	0.000549	CbGpPWpGaD
Spironolactone—AR—Gene Expression—NOTCH1—head and neck cancer	6.99e-05	0.000539	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	6.97e-05	0.000538	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—TYMS—head and neck cancer	6.9e-05	0.000532	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—GSTM1—head and neck cancer	6.82e-05	0.000526	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—NAT2—head and neck cancer	6.78e-05	0.000523	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	6.59e-05	0.000508	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—GPX1—head and neck cancer	6.53e-05	0.000504	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—CYP1A1—head and neck cancer	6.46e-05	0.000498	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	6.27e-05	0.000484	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	6.27e-05	0.000484	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—PTEN—head and neck cancer	6.2e-05	0.000478	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—PTGS2—head and neck cancer	6.13e-05	0.000473	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—NOTCH1—head and neck cancer	5.97e-05	0.00046	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—DPYD—head and neck cancer	5.95e-05	0.000459	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—NAT2—head and neck cancer	5.91e-05	0.000456	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—YAP1—head and neck cancer	5.64e-05	0.000435	CbGpPWpGaD
Spironolactone—NR3C2—Gene Expression—AKT1—head and neck cancer	5.62e-05	0.000434	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	5.44e-05	0.00042	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—PTEN—head and neck cancer	5.35e-05	0.000412	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	5.31e-05	0.00041	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—NOTCH1—head and neck cancer	5.3e-05	0.000409	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	5.27e-05	0.000406	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—DPYD—head and neck cancer	5.18e-05	0.0004	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—MAPK3—head and neck cancer	5.08e-05	0.000392	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—YAP1—head and neck cancer	4.92e-05	0.000379	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	4.45e-05	0.000343	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—PIK3CA—head and neck cancer	4.38e-05	0.000338	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	4.24e-05	0.000327	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—IL2—head and neck cancer	4.11e-05	0.000317	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CCND1—head and neck cancer	4e-05	0.000309	CbGpPWpGaD
Spironolactone—AR—Gene Expression—MAPK3—head and neck cancer	3.87e-05	0.000298	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PTEN—head and neck cancer	3.86e-05	0.000298	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PTGS2—head and neck cancer	3.84e-05	0.000296	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—PIK3CA—head and neck cancer	3.77e-05	0.000291	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	3.7e-05	0.000285	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—AKT1—head and neck cancer	3.57e-05	0.000276	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—VEGFA—head and neck cancer	3.49e-05	0.000269	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—STAT3—head and neck cancer	3.46e-05	0.000267	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—AKT1—head and neck cancer	3.42e-05	0.000264	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—TYMS—head and neck cancer	3.39e-05	0.000261	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PTEN—head and neck cancer	3.35e-05	0.000259	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—GSTM1—head and neck cancer	3.35e-05	0.000258	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—MAPK3—head and neck cancer	3.3e-05	0.000255	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—GPX1—head and neck cancer	3.21e-05	0.000247	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CYP1A1—head and neck cancer	3.18e-05	0.000245	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—MAPK1—head and neck cancer	3.14e-05	0.000242	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—EGFR—head and neck cancer	3.14e-05	0.000242	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—AKT1—head and neck cancer	3.08e-05	0.000238	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—TYMS—head and neck cancer	2.95e-05	0.000228	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—MAPK3—head and neck cancer	2.93e-05	0.000226	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—GSTM1—head and neck cancer	2.92e-05	0.000225	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—GPX1—head and neck cancer	2.79e-05	0.000216	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CYP1A1—head and neck cancer	2.77e-05	0.000213	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PIK3CA—head and neck cancer	2.73e-05	0.00021	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—TP53—head and neck cancer	2.64e-05	0.000203	CbGpPWpGaD
Spironolactone—AR—Gene Expression—AKT1—head and neck cancer	2.61e-05	0.000201	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	2.61e-05	0.000201	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—HRAS—head and neck cancer	2.52e-05	0.000195	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PIK3CA—head and neck cancer	2.36e-05	0.000182	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—AKT1—head and neck cancer	2.23e-05	0.000172	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—AKT1—head and neck cancer	1.98e-05	0.000153	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—AKT1—head and neck cancer	1.93e-05	0.000149	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PTGS2—head and neck cancer	1.89e-05	0.000146	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PTEN—head and neck cancer	1.65e-05	0.000127	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PTGS2—head and neck cancer	1.65e-05	0.000127	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PTEN—head and neck cancer	1.43e-05	0.000111	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PIK3CA—head and neck cancer	1.16e-05	8.96e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PIK3CA—head and neck cancer	1.01e-05	7.81e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—AKT1—head and neck cancer	9.49e-06	7.32e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—AKT1—head and neck cancer	8.27e-06	6.38e-05	CbGpPWpGaD
